Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DA78ZH
|
|||
| Drug Name |
MEDI5395
|
|||
| Drug Type |
Oncolytic virus therapy
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [1] | |
| Company |
AstraZeneca
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03889275) A Study of MEDI5395 in Combination With Durvalumab in Subjects With Select Advanced Solid Tumors. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.